Peptides Unleashed is run by a small editorial team that builds and maintains every dosage chart, protocol guide, and peptide explainer on the site. We are not a medical practice and we do not give medical advice. What we do is take published peptide research — clinical studies, vendor Certificates of Analysis, regulatory guidance, and primary literature on peptide pharmacology — and translate it into reference material that the research community can actually use. Every page on this site is meant to be read alongside, not in place of, advice from a qualified healthcare professional.
We are open about what we are, what we are not, and where our information comes from. This page documents how we work so you can judge our content for yourself.
Our Editorial Standards
The team commits to the following standards on every page we publish:
- Cite primary research. When we describe a peptide’s mechanism, half-life, or clinical effect, we work from peer-reviewed studies, clinical trial registries, and pharmacology references. Links to source material live inside the article body, not buried in a footnote nobody clicks.
- Flag speculative claims. If a benefit is anecdotal, theoretical, or only supported by in-vitro or animal work, we say so in the text. We do not present preclinical findings as if they were established clinical outcomes.
- No medical advice. Peptides Unleashed publishes educational and research-oriented content. We do not prescribe, diagnose, or recommend treatment. Every article carries an informational-purposes disclaimer.
- Update dates. Every page on the site shows a “last updated” date. When new research, new dosing data, or corrected information becomes available, we update the page and bump the date — we do not silently rewrite history.
- Correct mistakes in public. If a reader, vendor, or expert flags an error and we can verify it, we fix the page and note the correction.
- No fabricated credentials. No member of the editorial team claims medical, pharmacological, or regulatory credentials that they do not hold. If we cite an expert, we name the expert and link to their published work.
How We Source Information
The information on Peptides Unleashed comes from four buckets:
- Published peptide research. PubMed-indexed studies, clinical trial registries (ClinicalTrials.gov, EU CTR), pharmacology textbooks, and primary research papers on peptide synthesis, pharmacokinetics, and clinical use.
- Third-party Certificates of Analysis (COAs). When we discuss a specific peptide’s purity, identity, or vendor reliability, we work from independent third-party COAs — typically HPLC and mass spectrometry results published by the vendor and, where available, cross-referenced against independent lab testing.
- Regulatory and pharmacopeial references. FDA guidance, EMA monographs, USP and BP standards for peptide handling, storage, and reconstitution.
- Subject-matter consultation. Where a topic sits beyond what published literature directly answers — for example, practical reconstitution workflows for research-grade peptides — we draw on conversations with practicing researchers, compounding professionals, and vendor technical staff. We do not present those conversations as peer-reviewed evidence, and we mark them clearly when we use them.
We do not cite anonymous forum posts, vendor marketing copy, or social media as primary sources. Where industry context matters — for example, comparing how vendors describe a product — we note that we are summarizing claims, not endorsing them.
Our Editorial Process
Every article on Peptides Unleashed moves through the same five-step process:
- Write. A draft is produced from an outline that maps each claim to a planned source. Dosing tables, reconstitution math, and cycle protocols are checked against primary references at the drafting stage rather than retrofitted later.
- Fact-check. A second pass walks every numerical claim — milligrams, micrograms, units, ratios, half-lives, study-population sizes — back to its source. If a claim cannot be traced to a citable reference, it is either removed or rewritten as a clearly-flagged inference.
- Source-cite. Inline links are placed against the specific claims they support, not at the bottom of the page. Where a study is open-access, we link to the full paper; where it is paywalled, we link to the PubMed abstract.
- Review. The page is read end-to-end against the editorial standards above — disclaimer present, dates current, claims supported, terminology consistent, dosing math correct, no fabricated expertise. Pages covering peptide dosing receive an extra dosing-math review before publication.
- Publish + maintain. The page goes live with a publish date. We schedule a follow-up review at roughly six- to twelve-month intervals, sooner if new research lands or a vendor’s COA data changes. Every revision updates the “last updated” date visible under the headline.
When we change something material — for example, an updated dosing range based on a new study — we note the change in the relevant section rather than overwriting the previous text without comment.
What We Are Not
To keep the boundaries clear:
- We are not a medical practice. Nothing on this site is a substitute for diagnosis, treatment, or advice from a licensed healthcare professional.
- We do not sell peptides on this page. The content on Peptides Unleashed is editorial. Where we link to vendors, we disclose any affiliate relationship in the link context.
- We do not employ in-house MDs, PhDs, or pharmacists. When a topic requires that level of expertise to evaluate, we cite the experts whose published work informs the article rather than implying internal credentials we do not have.
- We do not personalize advice. Articles are written for a general research-oriented audience. They are not tailored to any individual’s physiology, conditions, or research protocol.
Contact the Editorial Team
If you have spotted a factual error, want to suggest a research source, or want to discuss an article on the site, the editorial team reads everything that comes in through the contact form.